$ANIP

Ani Pharmaceuticals Inc

Nasdaq · Healthcare · Pharmaceutical Preparations · Princeton, NJ

ANIP chart

What traders are saying about $ANIP

Latest posts

Ani Pharmaceuticals Inc news

Ani Pharmaceuticals Inc key financials

USD2025202420232022
Revenue$883.4M$614.4M$486.8M$316.4M
Net income$78.0M-$19.0M$19.0M-$48.0M
Diluted EPS$3.32$-1.04$0.85$-3.05
Total assets (year end)$1.44B$1.28B$904.4M$760.1M
Cash and equivalents (year end)$285.6M$144.9M$221.1M$48.2M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Ani Pharmaceuticals Inc

Ticker
ANIP (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Princeton, NJ
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1023024
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC

Frequently asked questions

What exchange is Ani Pharmaceuticals Inc listed on?

Ani Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol ANIP.

What industry is Ani Pharmaceuticals Inc in?

Ani Pharmaceuticals Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Ani Pharmaceuticals Inc headquartered?

Ani Pharmaceuticals Inc's business address on file with the SEC is in Princeton, NJ.

When does Ani Pharmaceuticals Inc's fiscal year end?

Ani Pharmaceuticals Inc's fiscal year ends on December 31.

How much revenue did Ani Pharmaceuticals Inc report?

Ani Pharmaceuticals Inc reported $883.4M in revenue for calendar year 2025, according to its SEC filings.